SEC Form 4 · accession 0000911916-16-000443
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Skwierczynski
Officer — Head,Pharmaceutical Operations
Period of report
Mar 4, 2016
Accepted (ET)
Mar 7, 2016 · 3:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.75 | Mar 4, 2016 | A | 15,000 | A | — | Mar 4, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.